Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02787954 · ClinicalTrials.gov registry record
Prospective Tumor Response Evaluation
A clinical trial, sponsored by The University of Texas Health Science Center, Houston.
- Terminated
- Registry status
- 10
- Enrollment target
NCT02787954 is a clinical trial that was terminated before completion, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 10 participants.
The verdict
NCT02787954 was terminated before completion, sponsored by The University of Texas Health Science Center, Houston.
- TERMINATED
- Registry status
- 10 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if MRI imaging can detect genetic, proteomic, and metabolomic characteristics of liver tumors. The study also aims to determine if these imaging characteristics are correlated with clinical outcomes.
Interventions
- PROCEDURE TACE
- PROCEDURE Y-90
- PROCEDURE MWA
- PROCEDURE IRE
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2016-01 |
| Est. Completion | 2017-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02787954
The ClinicalTrials.gov registry entry for NCT02787954 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which TACE is the first listed.
NCT02787954 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02787954 about?
NCT02787954 is a clinical study titled "Prospective Tumor Response Evaluation". The purpose of this study is to determine if MRI imaging can detect genetic, proteomic, and metabolomic characteristics of liver tumors. The study also aims to determine if these imaging characteristics are correlated with clinical outcomes.
What is the current status of trial NCT02787954?
This trial is currently terminated. The enrollment target is 10 participants. The study started on 2016-01. Estimated completion is 2017-04.
What interventions are being tested in trial NCT02787954?
The interventions under investigation include: TACE (PROCEDURE), Y-90 (PROCEDURE), MWA (PROCEDURE), IRE (PROCEDURE).
Who is sponsoring clinical trial NCT02787954?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.